Variability of clinical manifestations in the child with Roifman syndrome

Introduction. Roifman syndrome is a rare hereditary autosomal recessive disease, often associated with primary immunodeficiency and spondyloepiphyseal dysplasia. The cause of the disease is a splicing disorder due to a mutation of the RNU4ATAC gene with the formation of an incorrect protein structure, which in turn leads to clinical polymorphism.

Purpose: demonstration of own clinical observation of the 5-year girl with Roifman syndrome.

Materials and methods. An analysis of the literature on the stigmas of dysembriogenesis, clinical manifestations, changes in the immune system that determine the formation of Roifman syndrome was carried out.

Results. The features of the course and variability of manifestations in the particular patient with Roifman syndrome are described. The variety and non-specificity of clinical symptoms in Roifman syndrome in the 5-year girl is shown. Timely diagnosis after complete sequencing by Sanger made it possible to identify a complex heterozygous mutation in the RNU4ATAC gene and start adequate therapy.

Contribution:
Zokirov N.Z., Zyabkin I.V., Sytkov V.V. — research concept and design;
Zokirov N.Z., Krutova A.V., Nikolaeva Y.S., Mukhortykh V.A. — material collection and processing;
Krutova A.V., Nikolaeva Y.S., Mukhortykh V.A. — text writing;
Zokirov N.Z., Isaeva E.P., Sytkov V.V., Mukhortykh V.A. — editing.
All co-authors — approval of the final version of the article, responsibility for the integrity of all part of the article.

Acknowledgment. The study had no sponsorship.

Conflict of interest. The authors declare no conflict of interest.

Received: April 12, 2023
Accepted: May 16, 2023
Published: June 27, 2023

1. Khaitov R.M. Immunology of the XXI century – victories and achievements. Acta naturae. 2012; 4(3): 6–10. https://elibrary.ru/pewkvh (in Russian)

2. Shcherbina A.Yu. Primary immunodeficiency – the realities of the XXI century. Voprosy gematologii, onkologii i immunopatologii v pediatrii. 2016; 15(1): 8–9. https://doi.org/10.20953/1726-1708-2016-1-8-9 https://elibrary.ru/wffzod (in Russian)

3. Schejter Y.D., Ovadia A., Alexandrova R., Thiruvahindrapuram B., Pereira S.L., Manson D.E., et al. A homozygous mutation in the stem II domain of RNU4ATAC causes typical Roifman syndrome. NPJ Genom Med. 2017; 2: 23. https://doi.org/10.1038/s41525-017-0024-5

4. Roifman C.M. Immunological aspects of a novel immunodeficiency syndrome that includes antibody deficiency with normal immunoglobulins, spondyloepiphyseal dysplasia, growth and developmental delay, and retinal dystrophy. Can. J. Allergy Clin. Immunol. 1997; 2: 94–8.

5. Roifman C.M. Antibody deficiency, growth retardation, spondyloepiphyseal dysplasia and retinal dystrophy: a novel syndrome. Clin. Genet. 1999; 55(2): 103–9. https://doi.org/10.1034/j.1399-0004.1999.550206.x

6. Benoit-Pilven C., Besson A., Putoux A., Benetollo C., Saccaro C., Guguin J., et al. Clinical interpretation of variants identified in RNU4ATAC, a non-coding spliceosomal gene. PLoS One. 2020; 15(7): e0235655. https://doi.org/10.1371/journal.pone.0235655

7. Almentina Ramos Shidi F., Cologne A., Delous M., Besson A., Putoux A., Leutenegger A.L., et al. Mutations in the non-coding RNU4ATAC gene affect the homeostasis and function of the Integrator complex. Nucleic. Acids. Res. 2023; 51(2): 712–27. https://doi.org/10.1093/nar/gkac1182

8. Clifford D., Fiachra Moloney F., Leahy T.R., Murray D.M. Roifman syndrome: a description of further immunological and radiological features. BMJ Case Rep. 2022; 15(4): e249109. https://doi.org/10.1136/bcr-2022-249109

9. de Vries P.J., McCartney D.L., McCartney E., Woolf D., Wozencroft D. The cognitive and behavioural phenotype of Roifman syndrome. J. Intellect. Disabil. Res. 2006; 50(9): 690–6. https://doi.org/10.1111/j.1365-2788.2006.00817.x

10. Hagiwara H., Matsumoto H., Uematsu K., Zaha K., Sekinaka Y., Miyake N., et al. Immunodeficiency in a patient with microcephalic osteodysplastic primordial dwarfism type I as compared to Roifman syndrome. Brain Dev. 2021; 43(2): 337–42. https://doi.org/10.1016/j.braindev.2020.09.007

11. Ballios B.G., Mandola A., Tayyib A., Tumber A., Garkaby J., Vong L., et al. Deep phenotypic characterization of the retinal dystrophy in patients with RNU4ATAC-associated Roifman syndrome. Eye (Lond.). 2023. https://doi.org/10.1038/s41433-023-02581-1

12. Mandel K., Grunebaum E., Benson L. Noncompaction of the myocardium associated with Roifman syndrome. Cardiol. Young. 2001; 11(2): 240–3. https://doi.org/10.1017/s1047951101000208

13. Robertson S.P., Rodda C., Bankier A. Hypogonadotrophic hypogonadism in Roifman syndrome. Clin. Genet. 2000; 57(6): 435–8. https://doi.org/10.1034/j.1399-0004.2000.570606.x

14. Heremans J., Garcia-Perez J.E., Turro E., Schlenner S.M., Casteels I., Collin R., et al. Abnormal differentiation of B cells and megakaryocytes in patients with Roifman syndrome. J. Allergy Clin. Immunol. 2018; 142(2): 630–46. https://doi.org/10.1016/j.jaci.2017.11.061

15. Bogaert D.J., Dullaers M., Kuehn H.S., Leroy B.P., Niemela J.E., De Wilde H., et al. Early–onset primary antibody deficiency resembling common variable immunodeficiency challenges the diagnosis of Wiedeman–Steiner and Roifman syndromes. Sci. Rep. 2017; 7(1): 3702. https://doi.org/10.1038/s41598-017-02434-4

16. Merico D., Roifman M., Braunschweig U., Yuen R.K., Alexandrova R., Bates A., et al. Compound heterozygous mutations in the noncoding RNU4ATAC cause Roifman Syndrome by disrupting minor intron splicing. Nat. Commun. 2015; 6: 8718. https://doi.org/10.1038/ncomms9718